Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
Clinical trial NCT03306264 · COMPLETED
Trial details
- NCT number
- NCT03306264
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-15
- Primary completion
- 2021-09-10
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.